1-5 of 5
Keywords: Androgen deprivation
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Therapies Used in Prostate Cancer Patients by European Urologists: Data on Indication with a Focus on Expectations, Perceived Barriers and Guideline Compliance Related to the Use of Bisphosphonates

Available to Purchase
Subject Area:
Further Areas
Axel Heidenreich, Wim P.J. Witjes, Truls E. Bjerklund-Johansen, Anup Patel, for the EAU Research Foundation
Journal: Urologia Internationalis
Urol Int (2012) 89 (1): 30–38.
https://doi.org/10.1159/000338810
Published Online: 13 June 2012
... PCa, and 55% of the urologists did not administer androgen deprivation maintenance therapy in patients with CRPC. Conclusions: BPs were frequently used in PCa with bone metastases, although current guidelines recommend their use only in CRPC. Standardized multidisciplinary educational programs should...
View article titled, Therapies Used in Prostate Cancer Patients by European Urologists: Data on Indication with a Focus on Expectations, Perceived Barriers and Guideline Compliance Related to the Use of Bisphosphonates
Open the PDF for Therapies Used in Prostate Cancer Patients by European Urologists: Data on Indication with a Focus on Expectations, Perceived Barriers and Guideline Compliance Related to the Use of Bisphosphonates in another window
Journal Articles

Long-Term Outcome of Patients with High-Risk Prostate Cancer following Radical Prostatectomy and Stage-Dependent Adjuvant Androgen Deprivation

Available to Purchase
Subject Area:
Further Areas
Martin Spahn, Christel Weiss, Pia Bader, Philipp Ströbel, Elmar W. Gerharz, Burkard Kneitz, Detlef Frohneberg
Journal: Urologia Internationalis
Urol Int (2010) 84 (2): 164–173.
https://doi.org/10.1159/000277593
Published Online: 04 March 2010
...Martin Spahn; Christel Weiss; Pia Bader; Philipp Ströbel; Elmar W. Gerharz; Burkard Kneitz; Detlef Frohneberg Purpose: To present the long-term outcome of high-risk prostate cancer patients treated by radical retropubic prostatectomy (RRP) and stage-dependent adjuvant androgen deprivation therapy...
View article titled, Long-Term Outcome of Patients with High-Risk Prostate Cancer following Radical Prostatectomy and Stage-Dependent Adjuvant Androgen Deprivation
Open the PDF for Long-Term Outcome of Patients with High-Risk Prostate Cancer following Radical Prostatectomy and Stage-Dependent Adjuvant Androgen Deprivation in another window
Journal Articles

Efficacy and Safety of Leuprorelin Acetate Depot for Prostate Cancer

Available to Purchase
Subject Area:
Further Areas
E. Kienle, G. Lübben
Journal: Urologia Internationalis
Urol Int (1996) 56 (Suppl. 1): 23–30.
https://doi.org/10.1159/000282865
Published Online: 04 February 2010
...% progression, and 3.9% no data available. The median time to progression was 12(15 ± 11) months. Median survival time calculated by Kaplan-Meier exceeded 42.5 months for patients on monotherapy and 30.9 months for those on combination therapy. Hot flushes which were related to androgen deprivation were...
View article titled, Efficacy and Safety of Leuprorelin Acetate Depot for Prostate Cancer
Open the PDF for Efficacy and Safety of Leuprorelin Acetate Depot for Prostate Cancer in another window
Journal Articles

Effects of Androgen Deprivation prior to Radical Prostatectomy in 375 Patients

Available to Purchase
Subject Area:
Further Areas
Ulf W. Tunn, O. Acar, A.J.W. Goldschmidt
Journal: Urologia Internationalis
Urol Int (1996) 56 (Suppl. 1): 6–12.
https://doi.org/10.1159/000282861
Published Online: 04 February 2010
...Ulf W. Tunn; O. Acar; A.J.W. Goldschmidt The effects of pharmacotherapeutic complete androgen deprivation treatment for 2 months before radical retropubic prostatectomy (RRP) were investigated in an open study in 375 patients. Prostate volume, tumor staging and prostate-specific antigen (PSA) were...
View article titled, Effects of Androgen Deprivation prior to Radical Prostatectomy in 375 Patients
Open the PDF for Effects of Androgen Deprivation prior to Radical Prostatectomy in 375 Patients in another window
Journal Articles

3-Month Formulation of Goserelin Acetate (‘Zoladex’ 10.8-mg Depot) in Advanced Prostate Cancer: Results from an Italian, Open, Multicenter Trial

Available to Purchase
Subject Area:
Further Areas
D. Fontana, M. Mari, A. Martinelli, C. Boccafoschi, C. Magno, M. Turriziani, S.S. Maymone, S. Cosciani Cunico, A. Zanollo, G. Montagna, M. Frongia, U. Jacobellis
Journal: Urologia Internationalis
Urol Int (2003) 70 (4): 316–320.
https://doi.org/10.1159/000070142
Published Online: 14 May 2003
... Ospedaliera Brotzu, Cagliari, e kUnità Operativa di Urologia, Azienda Policlinico di Bari, Bari, Italia Key Words Prostate cancer W Testosterone W Prostate-specific antigen W Goserelin acetate W Androgen deprivation Abstract Objectives: To determine the endocrine effects, efficacy and tolerability of the 3...
View article titled, 3-Month Formulation of Goserelin Acetate (‘Zoladex’ 10.8-mg Depot) in Advanced Prostate Cancer: Results from an Italian, Open, Multicenter Trial
Open the PDF for 3-Month Formulation of Goserelin Acetate (‘Zoladex’ 10.8-mg Depot) in Advanced Prostate Cancer: Results from an Italian, Open, Multicenter Trial in another window